Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.2, 2011-07, pp. : 301-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Snail: a target for treating basal-like breast cancer

By Dong Chenfang Zhou Binhua P

Breast Cancer Management, Vol. 2, Iss. 4, 2013-07 ,pp. : 259-262

Future Medicine

Access to resources Recommend Favorite

High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation

By Antalis Caryl Arnold Tyler Rasool Tamkeen Lee Bonggi Buhman Kimberly Siddiqui Rafat

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 661-670

Springer Publishing Company

Access to resources Recommend Favorite

Gene-expression analysis and the basal-like breast cancer subtype

By Finnegan Timothy J Carey Lisa A

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 55-63

Future Medicine

Access to resources Recommend Favorite

5‐Chloro‐2,4‐dihydroxypyridine, CDHP, prevents lung metastasis of basal‐like breast cancer cells by reducing nascent adhesion formation

Cancer Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 463-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1

Oncology Reports, Vol. 30, Iss. 2, 2013-01 ,pp. : 877-889

Spandidos Publications

Access to resources Recommend Favorite